Document is current
Any future updates will be listed below
-
Authors
Wrobel, Maria M.
Cahalane, Alexis M.
Pachamanova, Dessislava
Leppelmann, Konstantin S.
Silverman, Stuart G.
Sharma, Amita
Shyn, Paul B.
Mercaldo, Nathaniel D.
Fintelmann, Florian J. https://orcid.org/0000-0002-0119-3903
- License Information
-
More Information
Article History
Received: 15 November 2021
Revised: 4 May 2022
Accepted: 21 May 2022
First Online: 15 June 2022
Declarations
:
: The scientific guarantor of this publication is Florian J. Fintelmann.
: Florian J. Fintelmann received salary support from the American Roentgen Ray Society and the William M. Wood Foundation during the study period, as well as research support from Boston Scientific. Amita Sharma reports research support from Hummingbird Diagnostics Inc. for unrelated work. The other authors have no relevant conflicts of interest to report.
: Nathaniel D. Mercaldo, PhD, is a biostatistician in the Department of Radiology at Massachusetts General Hospital and performed the statistical analysis for this manuscript.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: The current study overlaps with two previously published reports (references #21, # 22) in that the clinical outcomes of 28 patients in the current study were previously described. The current study differs significantly because it focuses only on imaging features following percutaneous lung ablation, regardless of clinical outcomes.
: • retrospective• observational• multicenter study
